Drug Profile
Research programme: signal transduction inhibitors - D.Western Therapeutics Institute
Latest Information Update: 28 Nov 2020
Price :
$50
*
At a glance
- Originator D. Western Therapeutics Institute
- Class
- Mechanism of Action Signal transduction pathway inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cardiovascular disorders; CNS disorders; Eye disorders; Respiration disorders
Most Recent Events
- 28 Nov 2020 No recent reports of development identified for research development in Cardiovascular-disorders in Japan
- 28 Nov 2020 No recent reports of development identified for research development in CNS-disorders in Japan
- 28 Nov 2020 No recent reports of development identified for research development in Eye-disorders in Japan